Endometriosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Endometriosis Treatment Market Report is Segmented by Type (Superficial Peritoneal Endometriosis, Endometriomas, Deeply Infiltrating Endometriosis, and Other Types), Treatment Type (Pain Medication, and Hormone Therapy), End User (Hospitals, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (USD) for the Above Segments.

Endometriosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Endometriosis Treatment Market Size

Global Endometriosis Treatment Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.77 Billion
Market Size (2030) USD 3.13 Billion
CAGR (2025 - 2030) 12.07 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Global Endometriosis Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Endometriosis Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Global Endometriosis Treatment Market Analysis

The Global Endometriosis Treatment Market size is estimated at USD 1.77 billion in 2025, and is expected to reach USD 3.13 billion by 2030, at a CAGR of 12.07% during the forecast period (2025-2030).

Endometriosis is the uterine pain that can be life-threatening if not treated properly. The surging burden of endometriosis and disorders like ovarian disorders and menstrual diseases are the major factors projected to drive the endometriosis treatment market. In addition, increased efforts to develop advanced approaches to manage endometriosis and favorable government legislation are supporting market expansion.

According to a March 2023 update by the World Health Organization, approximately 10% (190 million) of women and girls of childbearing age worldwide were affected by endometriosis. The condition is common in females and can start at a person’s first menstrual period and last until menopause. Moreover, according to December 2023 data from Endometriosis UK, the condition is common across the United Kingdom and affects 1 in every 10 women. Thus, the high burden of endometriosis among women is expected to accelerate market growth over the forecast period.

In addition, increasing awareness of the disease and the growing need for early detection are among the major factors driving the market's growth. For instance, Endometriosis Association Inc. is one of the leading non-profit organizations that provides support to women suffering from endometriosis and creates awareness about the condition. Moreover, the organization provides funds and grants to universities and research institutes to discover breakthrough therapies for endometriosis. Thus, such initiatives are anticipated to propel the endometriosis treatment market over the coming years.

Additionally, increased funding and grants from various government and non-government organizations to support endometriosis research are boosting the market’s growth. For instance, in March 2023, researchers at the University of Edinburgh, Aberdeen, and Birmingham received USD 3,00,000 in funding from the Wellbeing of Women and the Scottish government to investigate the efficiency of dichloroacetate in treating endometriosis. In addition, in September 2023, Endometriosis New Zealand granted a research fund to advance the understanding of various treatment approaches to treat endometriosis. This research aimed to investigate various approaches that can be crucial to manage this life-threatening condition. Thus, such funding and grants are anticipated to propel the market’s growth over the forecast period.

Though the abovementioned factors are anticipated to boost the market’s growth over the forecast period, the high cost of endometriosis treatment will likely impede this growth.

Global Endometriosis Treatment Industry Overview

The endometriosis treatment market is fragmented in nature due to the presence of several companies operating globally and regionally. Most of the major players focus on R&D to bring innovative products to the market. Some of the major players include Bayer AG, ObsEva, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Cipla, Teva Pharmaceutical Industries Ltd, AstraZeneca, TerSera Therapeutics USA, Tolmar Inc., AbbVie, and Sandoz AG.

Global Endometriosis Treatment Market Leaders

  1. Bayer AG

  2. Pfizer Inc.

  3. AbbVie Inc.

  4. Teva Pharmaceutical Industries

  5. AstraZeneca

  6. *Disclaimer: Major Players sorted in no particular order
Endometriosis Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Global Endometriosis Treatment Market News

  • May 2023: Abbott announced plans to launch an advanced version of dydrogesterone for the treatment of endometriosis-related pelvic pain. Dydrogesterone has a role in managing pain associated with endometriosis. It is also used to manage irregular cycles and dysfunctional uterine bleeding.
  • February 2023: Chugai Pharmaceutical Co. Ltd, Tsukuba Primate Research Center, NIBIOHN, and Jichi Medical University Saitama Medical Center announced the publication of AMY109 in the US scientific journal Science Translational Medicine. AMY109 is being investigated for its role in managing inflammation associated with endometriosis.

Global Endometriosis Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Driver
    • 4.2.1 Rising Prevalence of Endometriosis
    • 4.2.2 Growing Awareness of the Disease and Rising Need for Early Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Treatment
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Superficial Peritoneal Endometriosis
    • 5.1.2 Endometriomas
    • 5.1.3 Deeply Infiltrating Endometriosis
    • 5.1.4 Other Types
  • 5.2 By Treatment Type
    • 5.2.1 Pain Medication
    • 5.2.2 Hormone Therapy
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Clinics
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 Pfizer Inc.
    • 6.1.3 Sun Pharmaceutical Industries Ltd
    • 6.1.4 Cipla Limited
    • 6.1.5 Teva Pharmaceutical Industries Ltd
    • 6.1.6 TerSera Therapeutics USA
    • 6.1.7 Tolmar Inc.
    • 6.1.8 AstraZeneca
    • 6.1.9 ObsEva
    • 6.1.10 AbbVie
    • 6.1.11 Sandoz AG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Endometriosis Treatment Industry Segmentation

As per the scope of the report, endometriosis is a medical condition in which tissues similar to the endometrium grow in ovaries and fallopian tubes. It can affect women of all ages, including teenagers, and cause pain or infertility. The endometriosis treatment market is segmented by type, treatment type, end user, and geography. By type, the market is segmented into superficial peritoneal endometriosis, endometriomas, deeply infiltrating endometriosis, and other types. By treatment type, the market is segmented into pain medication and hormone therapy. By end user, the market is segmented into hospitals, specialty clinics, and other end users. The report also covers the market sizes and forecasts for the endometriosis treatment market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).

By Type Superficial Peritoneal Endometriosis
Endometriomas
Deeply Infiltrating Endometriosis
Other Types
By Treatment Type Pain Medication
Hormone Therapy
By End User Hospitals
Specialty Clinics
Other End Users
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Global Endometriosis Treatment Market Research Faqs

How big is the Global Endometriosis Treatment Market?

The Global Endometriosis Treatment Market size is expected to reach USD 1.77 billion in 2025 and grow at a CAGR of 12.07% to reach USD 3.13 billion by 2030.

What is the current Global Endometriosis Treatment Market size?

In 2025, the Global Endometriosis Treatment Market size is expected to reach USD 1.77 billion.

Who are the key players in Global Endometriosis Treatment Market?

Bayer AG, Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries and AstraZeneca are the major companies operating in the Global Endometriosis Treatment Market.

Which is the fastest growing region in Global Endometriosis Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Endometriosis Treatment Market?

In 2025, the North America accounts for the largest market share in Global Endometriosis Treatment Market.

What years does this Global Endometriosis Treatment Market cover, and what was the market size in 2024?

In 2024, the Global Endometriosis Treatment Market size was estimated at USD 1.56 billion. The report covers the Global Endometriosis Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Endometriosis Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Endometriosis Treatment Industry Report

Statistics for the 2025 Global Endometriosis Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Endometriosis Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.